Solicitor Says U.S. Supreme Court Should Deny Petition In Patent, Antitrust Case
WASHINGTON, D.C. — A petition by drug manufacturers asking the U.S. Supreme Court to consider “whether a reverse-payment agreement is immune from antitrust scrutiny if the consideration given by the brand-name...To view the full article, register now.
Already a subscriber? Click here to view full article